{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:46:07Z","timestamp":1792093567038,"version":"4.4.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-003174, INV-016832"],"award-info":[{"award-number":["INV-003174, INV-016832"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1202541"],"award-info":[{"award-number":["OPP1202541"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1202541"],"award-info":[{"award-number":["OPP1202541"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1202541"],"award-info":[{"award-number":["OPP1202541"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1202541"],"award-info":[{"award-number":["OPP1202541"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["16\/137\/109, NIHR200929, NIHR200908"],"award-info":[{"award-number":["16\/137\/109, NIHR200929, NIHR200908"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["NIHR200908"],"award-info":[{"award-number":["NIHR200908"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["101003688"],"award-info":[{"award-number":["101003688"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"name":"HDR UK","award":["MR\/S003975\/1"],"award-info":[{"award-number":["MR\/S003975\/1"]}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_PC 19065"],"award-info":[{"award-number":["MC_PC 19065"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>How best to prioritise COVID-19 vaccination within and between countries has been a public health and an ethical challenge for decision-makers globally. We reviewed epidemiological and economic modelling evidence on population priority groups to minimise COVID-19 mortality, transmission, and morbidity outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched the National Institute of Health iSearch COVID-19 Portfolio (a database of peer-reviewed and pre-print articles), Econlit, the Centre for Economic Policy Research, and the National Bureau of Economic Research for mathematical modelling studies evaluating the impact of prioritising COVID-19 vaccination to population target groups. The first search was conducted on March 3, 2021, and an updated search on the LMIC literature was conducted from March 3, 2021, to September 24, 2021. We narratively synthesised the main study conclusions on prioritisation and the conditions under which the conclusions changed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The initial search identified 1820 studies and 36 studies met the inclusion criteria. The updated search on LMIC literature identified 7 more studies. 43 studies in total were narratively synthesised. 74% of studies described outcomes in high-income countries (single and multi-country). We found that for countries seeking to minimise deaths, prioritising vaccination of senior adults was the optimal strategy and for countries seeking to minimise cases the young were prioritised. There were several exceptions to the main conclusion, notably\u00a0that reductions in deaths could be increased if groups at high risk of both transmission and death could be further identified. Findings were also sensitive to the level of vaccine coverage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The evidence supports WHO SAGE recommendations on COVID-19 vaccine prioritisation. There is,\u00a0however, an evidence gap on optimal prioritisation for low- and middle-income countries, studies that included an economic evaluation, and studies that explore prioritisation strategies if the aim is to reduce overall health burden including morbidity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12916-021-02190-3","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T21:03:18Z","timestamp":1638306198000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Models of COVID-19 vaccine prioritisation: a systematic literature search and narrative review"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5299-5052","authenticated-orcid":false,"given":"Nuru","family":"Saadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y-Ling","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srobana","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalind M.","family":"Eggo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciara V.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Quaife","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanette","family":"Dawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Jit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Vassall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,1]]},"reference":[{"key":"2190_CR1","unstructured":"WHO Coronavirus (COVID-19) Dashboard. https:\/\/covid19.who.int\/. Accessed 20 Sept 2021."},{"key":"2190_CR2","unstructured":"World Health Organization. WHO SAGE values framework for the allocation and prioritization of COVID-19 vaccination. https:\/\/www.who.int\/publications\/i\/item\/whosage- values-framework-for-the-allocation-and-prioritization-of-covid-19-vaccination. Accessed 8 June 2021."},{"key":"2190_CR3","unstructured":"World Health Organization. WHO Strategic Advisory Group of Experts (SAGE) on Immunization Working Group on COVID-19 Vaccines: Prioritized Infectious Disease and Economic Modelling Questions. https:\/\/www.who.int\/immunization\/policy\/sage\/SAGE_WG_COVID19_Vaccines_Modelli ng_Questions_31July2020.pdf. Accessed 8 June 2021."},{"key":"2190_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700. https:\/\/doi.org\/10.1136\/bmj.b2700.","journal-title":"BMJ"},{"key":"2190_CR5","unstructured":"Popay J, Roberts H, Sowden A, Pettricrew M, Arai L, Rodgers M et al. Guidance on the Conduct of Narrative Synthesis in Systematic Reviews. https:\/\/www.lancaster.ac.uk\/media\/lancaster-university\/contentassets\/ documents\/fhm\/dhr\/chir\/NSsynthesisguidanceVersion1-April2006.pdf. Accessed 8 June 2021."},{"key":"2190_CR6","unstructured":"World Bank Country and Lending Groups. https:\/\/datahelpdesk.worldbank.org\/knowledgebase\/articles\/906519-world-bank-country and-lending-groups. Accessed 8 June 2021."},{"key":"2190_CR7","doi-asserted-by":"publisher","unstructured":"Jentsch P, Anand M, Bauch CT. Prioritising COVID-19 vaccination in changing social and epidemiological landscapes. medRxiv. https:\/\/doi.org\/10.1101\/2020.09.25.20201889.","DOI":"10.1101\/2020.09.25.20201889"},{"key":"2190_CR8","doi-asserted-by":"publisher","unstructured":"Meehan MT, Cocks DG, Caldwell JM, Trauer JM, Adekunle AI, Ragonnet RR, et al. Agetargeted dose allocation can halve COVID-19 vaccine requirements. medRxiv. https:\/\/doi.org\/10.1101\/2020.10.08.20208108.","DOI":"10.1101\/2020.10.08.20208108"},{"key":"2190_CR9","unstructured":"Hogan BA, Winskill P, Watson OJ, Walker PGT, Whittaker C, Baguelin M et al. Report 33: Modelling the allocation and impact of a COVID-19 vaccine. https:\/\/www.imperial.ac.uk\/mrc-global-infectious-disease-analysis\/covid-19\/report-33-vaccine\/. Accessed 8 June 2021."},{"key":"2190_CR10","doi-asserted-by":"publisher","unstructured":"Chen X, Li M, Simchi-Levi D, Zhao T. Allocation of COVID-19 Vaccines Under Limited Supply. medRxiv. https:\/\/doi.org\/10.1101\/2020.08.23.20179820.","DOI":"10.1101\/2020.08.23.20179820"},{"key":"2190_CR11","doi-asserted-by":"publisher","unstructured":"Moore S, Hill EM, Dyson L, Tildesley MJ. Keeling MJ, Modelling optimal vaccination strategy for SARS-CoV-2 in the UK. medRxiv. https:\/\/doi.org\/10.1101\/2020.09.22.20194183.","DOI":"10.1101\/2020.09.22.20194183"},{"key":"2190_CR12","doi-asserted-by":"publisher","unstructured":"Bubar KM, Kissler SM, Lipsitch M, Cobey S, Grad Y. Larremore DB, Model-informed COVID-19 vaccine prioritization strategies by age and serostatus. medRxiv. https:\/\/doi.org\/10.1101\/2020.09.08.20190629.","DOI":"10.1101\/2020.09.08.20190629"},{"key":"2190_CR13","unstructured":"Chhetri B, Vamsi DKK, Balasubramanian S. Sanjeevic CB, Optimal Vaccination and Treatment Strategies in Reduction of COVID-19 Burden. arXiv. https:\/\/arxiv.org\/abs\/2102.09802v1."},{"key":"2190_CR14","unstructured":"Minoza JMA, Bongolan VP, Rayo JF. COVID-19 Agent-Based Model with Multiobjective Optimization for Vaccine Distribution. arXiv. https:\/\/arxiv.org\/abs\/2101.11400v1."},{"key":"2190_CR15","doi-asserted-by":"publisher","unstructured":"Hoertel N, Blachier M, Limosin F, Sanchez-Rico M, Blanco C, Olfson M, et al. Optimizing SARS-CoV-2 vaccination strategies in France: Results from a stochastic agent-based model. medRxiv. https:\/\/doi.org\/10.1101\/2021.01.17.21249970.","DOI":"10.1101\/2021.01.17.21249970"},{"key":"2190_CR16","doi-asserted-by":"publisher","unstructured":"Tran TNA, Wikle N, Albert J, Inam H, Strong E, Brinda K, et al. Optimal SARS-CoV-2 vaccine allocation using real-time seroprevalence estimates in Rhode Island and Massachusetts. medRxiv. https:\/\/doi.org\/10.1101\/2021.01.12.21249694.","DOI":"10.1101\/2021.01.12.21249694"},{"key":"2190_CR17","doi-asserted-by":"publisher","unstructured":"Foy BH, Wahl B, Mehta K, Shet A, Menon GI, Britto C. Comparing COVID-19 vaccine allocation strategies in India: a mathematical modelling study. medRxiv. https:\/\/doi.org\/10.1101\/2020.11.22.20236091.","DOI":"10.1101\/2020.11.22.20236091"},{"key":"2190_CR18","doi-asserted-by":"publisher","unstructured":"Bertsimas D, Ivanhoe J, Jacquillat A, Li M, Previero A, Lami OS. et al, Optimizing Vaccine Allocation to Combat the COVID-19 Pandemic. medRxiv. 2020. https:\/\/doi.org\/10.1101\/2020.11.17.20233213.","DOI":"10.1101\/2020.11.17.20233213"},{"key":"2190_CR19","doi-asserted-by":"publisher","unstructured":"Pearson CAB, Bozzani F, Procter SR, Davies NG, Huda M, Jensen HT, et al. Health impact and cost-effectiveness of COVID-19 vaccination in Sindh Province Pakistan. medRxiv. https:\/\/doi.org\/10.1101\/2021.02.24.21252338.","DOI":"10.1101\/2021.02.24.21252338"},{"issue":"9","key":"2190_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1009346","volume":"17","author":"N Gozzi","year":"2021","unstructured":"Gozzi N, Bajardi P, Perra N. The importance of non-pharmaceutical interventions during the COVID-19 vaccine rollout. PLoS Comput Biol. 2021;17(9):e1009346. https:\/\/doi.org\/10.1371\/journal.pcbi.1009346.","journal-title":"PLoS Comput Biol"},{"key":"2190_CR21","doi-asserted-by":"publisher","unstructured":"Espa\u00f1a G, Cucunuba ZM, Cuervo-Rojas J, Diaz H, Gonz\u00e1lez-Mayorga M, Ramirez JD. The impact of vaccination strategies for COVID-19 in the context of emerging variants and increasing social mixing in Bogot\u00e1, Colombia: a mathematical modelling study. medRxix. https:\/\/doi.org\/10.1101\/2021.08.06.21261734.","DOI":"10.1101\/2021.08.06.21261734"},{"key":"2190_CR22","doi-asserted-by":"publisher","first-page":"e048874","DOI":"10.1136\/bmjopen-2021-048874","volume":"11","author":"S Mandel","year":"2021","unstructured":"Mandel S, Arinaminpathy N, Bhargava B, Samiran P. India's pragmatic vaccination strategy against COVID-19: a mathematical modelling-based analysis. BMJ Open. 2021;11:e048874. https:\/\/doi.org\/10.1136\/bmjopen-2021-048874.","journal-title":"BMJ Open"},{"key":"2190_CR23","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.idm.2021.05.003","volume":"6","author":"EL Campos","year":"2021","unstructured":"Campos EL, Cysne RP, Madureira AL, GLQ M. Multi-generational SIR modeling: Determination of parameters, epidemiological forecasting and age-dependent vaccination policies. Infect Dis Model. 2021;6:751\u201365. https:\/\/doi.org\/10.1016\/j.idm.2021.05.003.","journal-title":"Infect Dis Model"},{"key":"2190_CR24","doi-asserted-by":"publisher","unstructured":"Goldstein JR, Cassidy T, Mahmud AS. Lives Saved from Age-Prioritized Covid-19 Vaccination. medRxiv. https:\/\/doi.org\/10.1101\/2021.03.19.21253991.","DOI":"10.1101\/2021.03.19.21253991"},{"key":"2190_CR25","doi-asserted-by":"publisher","unstructured":"Yu H, Han S, Cai J, Yang J, Zhang J, Wu Q, et al. Dynamic optimization of COVID-19 vaccine prioritization in the context of limited supply. Res Square. https:\/\/doi.org\/10.21203\/rs.3.rs-257573\/v1.","DOI":"10.21203\/rs.3.rs-257573\/v1"},{"key":"2190_CR26","doi-asserted-by":"publisher","unstructured":"Wang X, Du Z, Johnson KE, Pasco RF, Fox SJ, Lachmann M. et al, The impacts of COVID-19 vaccine timing, number of doses, and risk prioritization on mortality in the US. medRxiv. https:\/\/doi.org\/10.1101\/2021.01.18.21250071.","DOI":"10.1101\/2021.01.18.21250071"},{"key":"2190_CR27","doi-asserted-by":"publisher","unstructured":"Matrajt L, Eaton J, Leung T, Brown ER. Vaccine optimization for COVID-19, who to vaccinate first? medRxiv. https:\/\/doi.org\/10.1101\/2020.08.14.20175257.","DOI":"10.1101\/2020.08.14.20175257"},{"issue":"4","key":"2190_CR28","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3390\/jcm10040591","volume":"10","author":"E Shim","year":"2021","unstructured":"Shim E. Optimal Allocation of the Limited COVID-19 Vaccine Supply in South Korea. J Clin Med. 2021;10(4):591.","journal-title":"J Clin Med"},{"key":"2190_CR29","doi-asserted-by":"publisher","unstructured":"Moret M, Filho TR, Mendes J, Murari T, Filho AN, Cordeiro A. et al, WHO vaccination protocol can be improved to save more lives. Res Square. https:\/\/doi.org\/10.21203\/rs.3.rs-148826\/v1.","DOI":"10.21203\/rs.3.rs-148826\/v1"},{"key":"2190_CR30","unstructured":"Santini S. Covid-19 vaccination strategies with limited resources -- a model based on social network graphs. arXiv. https:\/\/arxiv.org\/abs\/2010.05312v1."},{"key":"2190_CR31","doi-asserted-by":"publisher","unstructured":"Hunziker P. Impact of personalized-dose vaccination in Covid-19 with a limited vaccine supply in a 100 day period in the U.S.A. medRxiv. https:\/\/doi.org\/10.1101\/2021.01.30.21250834.","DOI":"10.1101\/2021.01.30.21250834"},{"key":"2190_CR32","doi-asserted-by":"publisher","unstructured":"Macintyre CR, Costantino V, Trent M. Modelling of COVID-19 vaccination strategies and herd immunity, in scenarios of limited and full vaccine supply in NSW, Australia. medRxiv. https:\/\/doi.org\/10.1101\/2020.12.15.20248278.","DOI":"10.1101\/2020.12.15.20248278"},{"key":"2190_CR33","doi-asserted-by":"publisher","unstructured":"Babus A, Das S, Lee S. The Optimal Allocation of Covid-19 Vaccines. medRxiv. https:\/\/doi.org\/10.1101\/2020.07.22.20160143.","DOI":"10.1101\/2020.07.22.20160143"},{"key":"2190_CR34","doi-asserted-by":"publisher","unstructured":"Buckner JH, Chowell G, Springborn MR. Dynamic Prioritization of COVID-19 Vaccines When Social Distancing is Limited for Essential Workers. medRxiv. https:\/\/doi.org\/10.1101\/2020.09.22.20199174.","DOI":"10.1101\/2020.09.22.20199174"},{"key":"2190_CR35","unstructured":"Rodr\u00edguez J, Pat\u00f3n M, Acu\u00f1a JM. COVID-19 vaccine prioritisation to the groups with the most interactions can substantially reduce total fatalities. medRxiv. https:\/\/www.medrxiv.org\/content\/10.1101\/2020.10.12.20211094v2."},{"key":"2190_CR36","doi-asserted-by":"publisher","unstructured":"Bonsall MB, Huntingford C, Rawson T. Optimal time to return to normality: parallel use of COVID-19 vaccines and circuit breakers. medRxiv. https:\/\/doi.org\/10.1101\/2021.02.01.21250877.","DOI":"10.1101\/2021.02.01.21250877"},{"key":"2190_CR37","doi-asserted-by":"publisher","unstructured":"Chen J, Hoops S, Marathe A, et al. Prioritizing allocation of COVID-19 vaccines based on social contacts increases vaccination effectiveness. medRxiv. https:\/\/doi.org\/10.1101\/2021.02.04.21251012.","DOI":"10.1101\/2021.02.04.21251012"},{"key":"2190_CR38","doi-asserted-by":"publisher","unstructured":"Goldenbogen B, Adler SO, Bodeit O, Wodke JAH, Escalera-Fanjul X, Korman A, et al. Optimality in COVID-19 vaccination strategies determined by heterogeneity in humanhuman interaction networks. medRxiv. https:\/\/doi.org\/10.1101\/2020.12.16.20248301.","DOI":"10.1101\/2020.12.16.20248301"},{"key":"2190_CR39","doi-asserted-by":"publisher","unstructured":"Luangasanatip N, Pan-Ngum W, Prawjaeng J, Saralamba S, White L, Aguas R, et al. Optimal vaccine strategy to control COVID-19 pandemic in middle-income countries: Modelling case study of Thailand. Res Square. https:\/\/doi.org\/10.21203\/rs.3.rs-270635\/v1.","DOI":"10.21203\/rs.3.rs-270635\/v1"},{"key":"2190_CR40","doi-asserted-by":"publisher","unstructured":"Visscher AD, Sutton B, Sutton T. Second-wave dynamics of COVID-19: Impact of behavioral changes, immunity loss, new strains, and vaccination. Res Square. https:\/\/doi.org\/10.21203\/rs.3.rs-195879\/v1.","DOI":"10.21203\/rs.3.rs-195879\/v1"},{"key":"2190_CR41","doi-asserted-by":"publisher","unstructured":"Fujimoto AB, Yildirim I, Keskinocak P. Significance of SARS-CoV-2 Specific Antibody Testing during COVID-19 Vaccine Allocation. medRxiv. https:\/\/doi.org\/10.1101\/2021.01.28.21250721.","DOI":"10.1101\/2021.01.28.21250721"},{"key":"2190_CR42","doi-asserted-by":"publisher","unstructured":"Shayak B, Sharma MM. COVID-19 Spreading Dynamics with Vaccination \u2013 Allocation Strategy, Return to Normalcy and Vaccine Hesitancy. medRxiv. https:\/\/doi.org\/10.1101\/2020.12.10.20247049.","DOI":"10.1101\/2020.12.10.20247049"},{"key":"2190_CR43","doi-asserted-by":"publisher","unstructured":"Bruningk SC, Klatt J, Stange M, Mari A, Brunner M, Roloff TC. et al, Determinants of SARS-CoV-2 transmission to guide vaccination strategy in a city. medRxiv. https:\/\/doi.org\/10.1101\/2020.12.15.20248130.","DOI":"10.1101\/2020.12.15.20248130"},{"key":"2190_CR44","doi-asserted-by":"publisher","unstructured":"Ayoub HH, Chemaitell H, Makhoul M, Al Kanaani Z, Al Kuwari E, Butt AA, et al. Epidemiological impact of prioritizing SARS-CoV-2 vaccination by antibody status: Mathematical modeling analyses. medRxiv. https:\/\/doi.org\/10.1101\/2021.01.10.21249382.","DOI":"10.1101\/2021.01.10.21249382"},{"key":"2190_CR45","doi-asserted-by":"publisher","unstructured":"Castonguay FM, Blackwood JC, Howerton E, Shea K, Sims C. Sanchirico JN, Spatial Allocation of Scarce Vaccine and Antivirals for COVID-19. medRxiv. https:\/\/doi.org\/10.1101\/2020.12.18.20248439.","DOI":"10.1101\/2020.12.18.20248439"},{"issue":"5","key":"2190_CR46","doi-asserted-by":"publisher","first-page":"462","DOI":"10.3390\/vaccines9050462","volume":"9","author":"A Fuady","year":"2021","unstructured":"Fuady A, Nuraini N, Sukander KK, Lestari BW. Targeted Vaccine Allocation Could Increase the COVID-19 Vaccine Benefits Amidst Its Lack of Availability: A Mathematical Modeling Study in Indonesia. Vaccines. 2021;9(5):462.","journal-title":"Vaccines"},{"key":"2190_CR47","doi-asserted-by":"publisher","unstructured":"Guerstein S, Romeo-Aznar V, Dekel M, Miron O, Davidovitch N, Puzis R, et al. Optimal strategies for combining vaccine prioritization and social distancing to reduce hospitalizations and mitigate COVID19 progression. medRxiv. https:\/\/doi.org\/10.1101\/2020.12.22.20248622.","DOI":"10.1101\/2020.12.22.20248622"},{"key":"2190_CR48","doi-asserted-by":"publisher","unstructured":"Kirwin E, Rafferty E, Harback K, Round J, McCabe C. A Net Benefit Approach for the Optimal Allocation of a COVID-19 Vaccine. medRxiv. https:\/\/doi.org\/10.1101\/2020.11.30.20240986.","DOI":"10.1101\/2020.11.30.20240986"},{"issue":"10278","key":"2190_CR49","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0140-6736(21)00306-8","volume":"397","author":"OJ Wouters","year":"2021","unstructured":"Wouters OJ, Shadlen KC, Salcher-Konrad M, Pollard AJ, Larson HJ, Teerawattananon Y, et al. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. Lancet. 2021;397(10278):1023\u2013934.","journal-title":"Lancet"},{"key":"2190_CR50","unstructured":"World Health Organization. WHO guide for standardization of economic evaluations of immunization programmes. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/329389\/WHO-IVB-19.10-eng.pdf. Accessed 8 June 2021."}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-021-02190-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-021-02190-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-021-02190-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T21:04:17Z","timestamp":1638306257000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-021-02190-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2190"],"URL":"https:\/\/doi.org\/10.1186\/s12916-021-02190-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.06.21.21259104","asserted-by":"object"}]},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"9 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"318"}}